Should You Buy Stocks in October? History’s Answer is Strikingly Clear.

The article argues that October’s historical volatility is not a reason to avoid stocks, citing positive S&P 500 returns in 66% of Octobers since 1991 and 61% since 1957. It notes the index is up double digits in 2026, while September fell 0.4%, inflation and an initial rate increase have weighed on growth stocks, and large technology companies have pledged nearly $700 billion in AI investment this year. The article favors long-term investing in quality stocks at reasonable valuations, while acknowledging concerns about whether future AI revenues will justify spending.

Analysis

The useful signal here is not October seasonality; it is the market’s dependence on a narrow set of large AI beneficiaries while their investment commitments increasingly need to convert into measurable revenue and productivity gains. Index-level resilience can therefore conceal rising concentration risk: disappointment in a few mega-cap names could pressure the cap-weighted benchmark and spill into semiconductor and data-center suppliers, even if the broader economy remains sound.

The historical case for holding equities is vulnerable to survivorship and starting-valuation effects. Long-run returns do not protect investors from multi-year drawdowns, inflation eroding real returns, or forced selling when liquidity is needed. A higher-rate environment would also challenge long-duration growth multiples before it necessarily changes the AI adoption thesis.

Over the next 1–3 months, focus on inflation and rate expectations, earnings revisions, and evidence that AI spending is producing incremental revenue or cost savings—not just larger budgets. Over 6–18 months, the key risk is capex digestion: weaker monetization could hit infrastructure suppliers first and then weaken the earnings narrative supporting concentrated index leadership. Conversely, durable customer demand and productivity evidence would validate investment levels and support the growth trade.

Contrarian read: the article’s reassuring historical framing may underweight concentration and valuation; however, seasonality alone is not a reason to short equities. There is no robust directional trade signal here without current valuation, positioning, and earnings data.

Key Decisions for Investors

• Avoid changing broad equity exposure solely because it is October. For new allocations, consider staged entry rather than an all-at-once market-timing bet; this reduces entry-point risk but does not eliminate drawdown risk.
• For a relative-value expression of concentration risk, monitor a cap-weighted S&P 500 exposure versus an equal-weight counterpart. Consider a modest relative tilt toward equal weight only if leadership broadens or mega-cap earnings revisions weaken; reverse it if breadth deteriorates or equal-weight earnings estimates are cut more sharply.
• Treat AI infrastructure exposure as conditional, not as a blanket sector long. Track hyperscaler capex plans against realized AI-related revenue, customer adoption, and supplier order trends; weaker monetization alongside sustained spending would be a warning to reduce exposure to the most capex-sensitive suppliers.
• Falsifiers and catalysts: persistent disinflation and falling rate expectations alongside improving earnings breadth would weaken the concentration-risk thesis. Renewed inflation, higher yields, downward earnings revisions, or evidence of delayed AI returns would strengthen it. Verify current valuations, positioning, and company-level monetization before sizing a trade.